Series: Pathologies in SME Credit

Which Are the Worst Business Credit Products for Brazilian SMEs — and Why

Across dozens of expert opinions prepared for Brazilian small and medium-sized companies, a recurring client question is: "is one credit product more dangerous than the others?" The technical answer is yes — and the difference is not just the nominal interest rate, but the product's structure: how it behaves over time, what happens if a payment is late, and how much discretionary power it leaves in the lender's hands once something departs from the original deal.

Based on the sample of audited operations — CCB (Brazilian business credit note), revolving credit line ("conta garantida"), commercial note and debt-confession instrument — a real comparative picture emerges, with one product standing out as technically the most dangerous: the revolving credit line, especially in the period after it matures or its limit is exceeded.

CCB — the most common, and the most variable in quality

The CCB (Cédula de Crédito Bancário) is today the most-used instrument for SME working capital in Brazil, including under public support lines (PRONAMPE, FGI-PEAC, BNDES Automático). It is also the most frequent product in the audited sample — the large majority of cases reviewed involved this instrument. That does not mean the CCB is, in itself, the most abusive product: it means it is the most contracted, and therefore concentrates the largest absolute number of observed pathologies — interest capitalization during the grace period, tax (IOF) miscalculation, layered collateral with no rate discount, subjective acceleration clauses.

The CCB has one structural advantage for the borrower: because it is a legally typed credit instrument (Law 10.931/2004), it carries minimum formal clarity requirements (amount, term, rate, payment method) that, when unmet, open meaningful technical room to challenge the instrument's liquidity and certainty.

Commercial notes — sophistication that also hides risk

The commercial note, a capital-markets instrument (Law 14.195/2021), tends to be used in larger operations, often structured by receivables investment funds (FIDC) rather than traditional banks. In one audited case, involving the repurchase of past-due receivables and the novation of stressed debt, an irreconcilable contradiction was found between the operation's total term (1,158 days) and the nominal maturity date stated in the instrument — a flaw that technically undermines the instrument's own legal certainty. Add to that interest capitalization during a grace period of over four months and a real-estate guarantee that had not even been registered, and was therefore nonexistent as to third parties. The instrument's sophistication, in this case, did not translate into greater borrower protection — the complexity made it harder to spot, without a forensic review, the defects built into the structure.

Debt confession — the risk of "renegotiating" for the worse

A debt-confession instrument usually arises not as new credit, but as consolidation of prior operations — in one audited case, 21 working-capital and revolving-limit operations were consolidated into a single instrument. The technical risk lies in what the forensic review called "compulsory rate arbitrage": the bank, in practice, forces the use of more expensive lines (like overdraft, at double-digit monthly rates) to pay off an originally cheaper debt, and the nominal installment on the consolidated confession is sometimes not even enough to cover the contracted interest — producing a debt that grows even with on-time payments.

Not sure whether your company's credit product is safe?

Request a preliminary technical screening of your contract — CCB, revolving credit line, commercial note or debt confession.

Request Screening

Revolving credit line — most dangerous after maturity

Among all products analyzed, the revolving credit line ("conta garantida") stood out technically as the riskiest — not during normal use of the limit, but after that limit matures or is exceeded. By design, this is a short-term revolving facility: the company draws on a pre-approved limit according to cash-flow needs and pays interest on the balance used. The most serious technical problem appears when the limit matures and is not renewed, or when the balance used exceeds the contracted ceiling.

In one audited case — a limit of roughly R$50,000 — the balance was unilaterally converted into a modality called "Adiantamento a Depositante" (advance to depositor), with no clear contractual basis for that conversion or for the rate that would then apply to the new balance. The technically reconstructed result: a debt that should have been corrected at market working-capital rates (roughly 4% per month on average) was, in practice, charged at 15% per month — over 400% annualized — with additional default interest and daily capitalization. An original R$50,000 limit generated a claimed debt of roughly R$188,000, an excess of about 79% over what the forensic review found actually owed.

This pattern — post-maturity conversion with no clear contractual basis, at a rate level far above what applied during the limit's normal life — appeared in more than one case in the sample involving revolving credit lines, suggesting this is not an isolated glitch but a structural feature of how this product is typically operated once a client exceeds the limit or fails to renew the line.

What this means if you are about to sign

No business credit product is "safe by definition" — each has its own specific points to watch:

ProductMain point to watch
CCBAudit the grace period (interest capitalization), IOF tax, and layered collateral
Commercial noteRequire clarity between term, maturity and formal registration of any real collateral
Debt confessionSimulate whether the new installment actually amortizes the balance before trading cheap debt for expensive debt
Revolving credit lineAsk in writing exactly what happens the day after the limit matures or is exceeded

The single most important practical rule, valid for any of these products, is this: the risk is rarely in what the contract states clearly. It is in what it leaves open — to be decided later, unilaterally, by the lender.

This article is part of a series on technical pathologies in business credit operations, based on expert opinions prepared by the author. Individual cases are treated in aggregate and anonymized form, with no identification of the companies or individuals involved.

Frequently asked questions

Which business credit product carries the most risk for a Brazilian SME?

Technically, the revolving credit line ("conta garantida") stands out as riskiest — not during normal use of the limit, but after it expires or is exceeded, when banks can unilaterally convert the balance into far more expensive modalities.

Is the CCB a dangerous credit product?

The CCB is not, in itself, the most abusive product — it is the most commonly used, and therefore concentrates the largest absolute number of observed pathologies, such as interest capitalization during grace periods, tax miscalculation, and layered collateral.

What should I check in a commercial note before accepting the deal?

Require absolute clarity between term, maturity date and the formal registration of any real collateral offered — contradictions among these elements can undermine the instrument's own legal certainty.

Does a debt-confession instrument always improve the debtor's situation?

Not necessarily. It is essential to independently simulate whether the new installment actually amortizes the consolidated balance, or whether it merely swaps cheaper debt for more expensive debt under the guise of a solution.

Dr. Lincoln Sposito

Dr. Lincoln Sposito

PhD in Business Administration | Judicial Expert Witness | Data Science (MIT)

Specialist in banking audits and financial forensics, combining the statistical rigor of data science with the analysis of banking-system architectures to dismantle predatory charges against SMEs. Learn more about the expert →

Request a Forensic Diagnosis of Your Contract

Before signing — or after — audit your Brazil-linked business credit contract with scientific forensic methodology.